Catalent (CTLT -0.4%) inks an agreement with Minerva Neurosciences (NERV -1.9%) to manufacture and supply schizophrenia med roluperidone (MIN-101). Catalent plans to make and package the product at its Schorndorf, Germany site. Financial terms are not disclosed.
https://seekingalpha.com/news/3501514-catalent-supply-roluperidone-minerva
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.